Samlyn Capital, LLC Cabaletta Bio, Inc. Transaction History

Samlyn Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.99 - $2.11 $150,305 - $320,348	151,824 Added 8.59%	1,919,907 $2.04 Million
Q1 2022 May 16, 2022	BUY	$1.68 - $3.92 $646,299 - $1.51 Million	384,702 Added 27.81%	1,768,083 $3.59 Million
Q4 2021 Feb 14, 2022	BUY	$3.36 - $14.64 $3.47 Million - $15.1 Million	1,033,906 Added 295.85%	1,383,381 $5.24 Million
Q3 2021 Nov 15, 2021	BUY	$7.0 - $12.5 $2.45 Million - $4.37 Million	349,475 New	349,475 $4.25 Million

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $76M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.